Big pharma leads the way in stock market resurgence

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 7, 2021 at 10:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via If the theme of the first quarter of 2021 was worry about a stock market correction, the second quarter was all about a resurgence on the back of Alzheimer’s optimism. It seems the FDA, with the controversial approval of Biogen’s Aduhelm, has come to the rescue of biopharma investors.

    article source